x
ServiziMenu principaleHome

Institut Gustave Roussy

Villejuif, France

Person responsible for CTC programme: Yohann Loriot

Hospital overview

Institut Gustave Roussy is one of the leading anti-cancer centres in Europe. Based at the Paris city gates, it is a hub of global expertise united against cancer and dedicated entirely to patients. On a single campus, it brings together more than 2.100 professionals who treat patients with all kinds of cancer, do research into and assess new treatments against cancer, and share the knowledge they have acquired with students.
In addition to bringing together treatment, research and teaching in an integrated environment, the Institut has distinguished itself through innovative organisation and positioning.

Visiting Residency is only available for EU residents with French skills at Institute Gustave Roussy.

CTC programmes offered

1. Gynecologic oncology: epithelial ovarian tumors and nonepithelial rare ovarian tumors, uterine carcinoma, uterine sarcoma, cervical and vaginal tumors
Programme mentors:

Alexandra Leary  (Biology), Patricia Pautier (Rare gynecologic tumors)
Both : all gynecologic tumors
Duration: 3 - 6 months
Type:

Residency  and/or translational research
Language requirements:

basic french spoken for residency; English or french speaking for research
Programme description:

Patients: adults

Specific oncologic courses dedicated to fellows 3 hours/ week, bibliography
Specific multidisciplinary staff : 1 x/week 4 hours 60 cases
Access to operating room for gynecologic tumors

2. Radiation oncology: solid tumor and hematologic malignancy
Programme mentors:

Antonin Levy/Cécile Le Péchoux (Thoracic Oncology and sarcomas)
Frédéric Dhermain  (Neuro-oncology)
Sofia Rivera (Breast)
Valentine Martin/Stéphanie Bolle (Hematology/Pediatrics)
Eric Deutsch/Jerome Durand-Labrunie (GI)
Alberto Bossi/Pierre Blanchard (Urology)
Yungan Tao/Pierre Blanchard/France Nguyen (Head and Neck)
Cyrus Chargari (Brachytherapy)
Duration: 3 - 6 months
Type:

Visiting Residency and visiting Observership
Language requirements: basic french spoken if visiting residency
Programme description:

Patients: Adult and children

Specific radiation oncology courses dedicated to fellows 4 hour/months
Patient care :  radiotherapy (10 linacs including stereotactic and IMRT: Cybeknife, Novalis, Tomotherapy, VERSA..), brachyerapy (6PDR beds, HDR) and hospitalisation (24 beds) units.
4200 patients /year
Local tumor board (4h/w), regional virtual tumor boards, specific working sessions (2h/week), bibliography, publications

3. Breast oncology: from prevention and diagnosis to full treatment at all stages, including all modalities; molecular medicine, therapeutic development
Programme mentors:

Suzette Delaloge (Breast cancer prevention, One Stop Units, Precision adjuvant Programs, Care organization)
Fabrice André (Precision Medicine programs, Molecular medicine Lab, Therapeutic development)
Barbara Pistilli (Cancer in young women, Drug development, adherence)
Ines Vaz Luis (survivorship)
Monica Arnedos (pre-operative WOPs, therapeutic development)
Duration: 3 - 6 months
Type: Visisting Residency (6 months) and visiting Observership (3 months)
Language requirements: basic French spoken
Programme description:

Patients: Men and women with breast cancer at all stages

Specific breast oncology courses dedicated to fellows 1/week
Scientific sessions: 1/week
Oncology courses: 1/week
Bibliography: 1/week
Multidisciplinary team sessions (tumor board): 6H00/week
Patient care : 2000 new patients/year (1200 breast cancers), outpatient clinics and care

4. Dermato-oncology: melanomas and carcinomas (squamous cell carcinomas, basal cell carcinomas, Merkel cell carcinomas)
Programme mentors:

Pr Caroline Robert
Dr Emilie Routier
Dr Cristina Libenciuc
Dr Jeremy Lupu
Duration: 3 - 6 months
Type: Visiting Residency and visiting Observership
Language requirements: basic french spoken
Programme description:

Patients : Adults mostly

Specific dermato-oncology courses dedicated to fellows once a month.
Patient care:  more than 17 000 consultations and 4000 acts of surgery each year. Day care hospital (clinical trials, immunotherapy and chemotherapy). Around 20 beds of hospitalization in the Department of Medical Oncology or in Surgery Department. Translational research in U981 research team on resistance mechanisms.

Local tumor board twice a week. Bibliography sessions.

5. Genito-urinary cancer: Prostate cancer, urothelial cancer, Kidney cancer, testis cancer, penile tumor
Programme mentors:

Pr Karim Fizazi
Dr Yohann Loriot
Dr Bernard Escudier
Dr Laurence Albigès
Dr Giulia Baciarello
Dr Pernelle Lavaud
Dr Ronan Flippot
Duration: 3 - 6 months
Type: Visiting Residency and visiting Observership
Language requirements: basic french spoken
Programme description:

Patients : Adults

Patient care:  consultations very day, day care hospital (clinical trials, immunotherapy, targeted therapies and chemotherapy). Beds in the Department of Medical Oncology. Translational research in U981 research team on resistance mechanisms.

Tumor board once a week. Bibliography sessions.

6. Department of phase 1 clinical trials.
Programme mentors:

Christophe MASSARD (phase 1 trials and GU cancer)
Sophie POSTEL-VINAY (Epigenetic and DNArepair)
Aurélien MARABELLE (immunotherapy)
Vincent RIBRAG (HEME disease and Phase 1)
Antoine HOLLEBECQUE (GI cancer and Phase 1)
Andrea VARGA (Breast cancer and Phase 1)
Duration: 3 - 6 months
Type: Visisting Residency and visiting Observership
Language requirements: basic French spoken or English
Programme description:

Patients: Adult patients with advanced cancer referred for phase 1 trials or molecular screening

Specific phase 1 trials courses dedicated to fellows 1hour/week
Patient care : 17 beds, day care hospital (16 beds)

Around 400-500 new patients /year enrolled in phase 1 trials, 500 patients enrolled in molecular screening

Local tumor board (2h/w),  specific working sessions (2h/week), bibliography

7. Thoracic tumors
Programme mentors:

Pr Benjamin Besse 
Dr David Planchard
Dr Charles Naltet
Dr Pernelle Lavaud
Duration: 3 - 6 months
Type: Visisting Residency and visiting Observership
Language requirements:

basic French spoken or English

Programme description:

Patients: Adult patients with lung cancer, mesothelioma and other rare chest tumors.

Consultations every day, day care hospital (clinical trials, immunotherapy, targeted therapies and chemotherapy). Beds in the Department of Medical Oncology. Translational research in U981 research team on resistance mechanisms.